Your browser doesn't support javascript.
loading
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma.
Schneller, Anja; Zojer, Niklas; Bolomsky, Arnold; Ludwig, Heinz.
Affiliation
  • Schneller A; Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna, Austria; Recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Wilhelminen Cancer Research Institute.
  • Zojer N; Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna.
  • Bolomsky A; Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna.
  • Ludwig H; Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna. heinz.ludwig@extern.gesundheitsverbund.at.
Haematologica ; 106(9): 2516-2521, 2021 09 01.
Article in En | MEDLINE | ID: mdl-33910332
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Haematologica Year: 2021 Type: Article